Prestige Consumer Healthcare Inc. (PBH) Q4 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals positive financial results, with revenue, gross margin, and net income showing year-over-year growth. However, supply chain constraints and high inflation pose significant risks. The absence of strategic initiatives and operational updates, combined with unclear management responses in the Q&A, tempers enthusiasm. The market cap indicates moderate sensitivity to news, suggesting a neutral stock price movement in the short term.
Key Financial Performance
Revenue Revenue for Q4 2026 was $300 million, representing a 5% increase year-over-year. The growth was driven by strong demand for core products and successful marketing campaigns.
Gross Margin Gross margin improved to 60%, up from 58% in the prior year. This 2% increase was attributed to cost-saving initiatives and favorable product mix.
Operating Income Operating income reached $75 million, a 7% increase compared to the previous year. The improvement was due to higher revenue and operational efficiencies.
Net Income Net income for the quarter was $50 million, up 6% year-over-year. This increase was driven by improved operating income and lower interest expenses.
Cash Flow from Operations Cash flow from operations was $65 million, a 10% increase from the prior year. The growth was attributed to better working capital management and higher profitability.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Supply Chain Constraints: The company is facing ongoing supply chain constraints, which could impact the availability of products and operational efficiency.
High Inflation: High inflation is creating a challenging business environment, potentially increasing costs and affecting profitability.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Andersen Blair
Anderson Canaccord
Blair LLC
CEO Christine
COO Anderson
Canaccord Genuity
Christine Sacco
Consumer Healthcare
Devas Jefferies
Development today
Director Investor
Division Jon
Division Keith
Division Lebiedzinski
Douglas Lane
EDT day
Healthcare Inc
Inc Philip
Investor Relations
Jefferies LLC
Jon Andersen
Keith Devas
LLC EDT
LLC Research
Prestige Consumer
Research Division
Sacco CFO
Treasury Development
conference Vice
uncertainty
PBH Transcript
Prestige Consumer Healthcare Inc. (PBH) Q4 2026 Earnings Call Transcript
Unknown5-14
The earnings call reveals positive financial results, with revenue, gross margin, and net income showing year-over-year growth. However, supply chain constraints and high inflation pose significant risks. The absence of strategic initiatives and operational updates, combined with unclear management responses in the Q&A, tempers enthusiasm. The market cap indicates moderate sensitivity to news, suggesting a neutral stock price movement in the short term.
Prestige Consumer Healthcare Inc. (PBH) Q3 2026 Earnings Call Transcript
Unknown2-5
The earnings call highlights mixed signals: strong e-commerce growth and product launches are positive, but inventory destocking and uncertain guidance create concerns. While management's optimism about Clear Eyes supply and stable margins is reassuring, the lack of specific guidance and volatility in retailer order patterns are drawbacks. Given the market cap, a neutral stock price movement is likely as positive and negative factors balance out.
Prestige Consumer Healthcare Inc. (PBH) Q2 2026 Earnings Call Transcript
Unknown11-6
The earnings call summary reflects a mix of positive and negative elements. Basic financial performance is challenged by supply chain issues and declining revenue guidance, while product development and market strategy show potential for recovery and growth. Expenses are manageable with expected cash flow, but the lack of clear guidance and uncertainties in specific areas like Clear Eyes recovery and e-commerce order patterns contribute to a neutral sentiment. Given the market cap, the stock is likely to experience minor fluctuations, resulting in a neutral prediction for the next two weeks.
Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 18th Annual Global Consumer Staples Conference 2025 Transcript
Neutral9-5
PBH Slides
PBH Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
